| No. | Recommendations | GR | LoE | Sources |
|---|---|---|---|---|
| * to treat patients with primary recurrence who did not have previous VEGF-targeted therapy | ||||
| 9.5. | Patients with platinum-sensitive recurrence of ovarian
cancer should have platinum-based combination therapy if
chemotherapy is indicated. The following combinations
can be used:
|
CC | ||
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.